H1N1 (Swine Flu) Vaccination Market Growth Drivers, Trends, and Forecast by 2031

Historic Data: 2021-2023   |   Base Year: 2024   |   Forecast Period: 2025-2031

Coverage: H1N1 (Swine Flu) Vaccination Market covers analysis By Delivery Device (Syringes, Jet Injectors, Other Devices); Route of Administration (Intradermal Vaccination, Intramuscular Vaccination, Subcutaneous Vaccination); End User (Hospitals, Ambulatory Surgical Centers, Clinic & Vaccination Centers) , and Geography (North America, Europe, Asia Pacific, and South and Central America)

  • Report Code : TIPRE00006730
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

MARKET INTRODUCTION



Swine flu is contamination of the respiratory system due to influenza viruses. The viruses also contaminate the respiratory system of pigs affecting the reduction in appetite, barking cough, nasal discharges, and listless behavior. The influenza viruses can also be communicated to humans. Swine flu viruses can produce genetic changes or mutations so that they are undoubtedly transmissible among humans. Vaccination is an essential method to prevent this disease.


MARKET DYNAMICS



H1N1 (swine flu) vaccination market is anticipated to grow in the forecast period owing to driving factors such as growing awareness about influenza A (swine flu, H1N1). Moreover, increase in health responsiveness in developing nations is also offering opportunities in the market growth during the forecast period.

MARKET SCOPE



The "Global H1N1 (swine flu) Vaccination Market Analysis to 2031" is a specialized and in-depth study of the pharmaceuticals industry with a special focus on the global market trend analysis. The report aims to provide an overview of H1N1 (swine flu) vaccination market with detailed market segmentation by delivery device, route of administration, end user, and geography. The global H1N1 (swine flu) vaccination market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading H1N1 (swine flu) vaccination market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION



The global H1N1 (swine flu) vaccination market is segmented on the basis of delivery device, route of administration, and end user. Based on delivery device, the market is segmented as syringes, jet injectors, and other devices. Based on route of administration, the market is segmented as intradermal vaccination, intramuscular vaccination, and subcutaneous vaccination. On the basis of end user, the global H1N1 (swine flu) vaccination market is divided into hospitals, ambulatory surgical centers, and clinic & vaccination centers.

REGIONAL FRAMEWORK



The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global H1N1 (swine flu) vaccination market based on various segments. It also provides market size and forecast estimates from year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The H1N1 (swine flu) vaccination market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting H1N1 (swine flu) vaccination market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trends. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the H1N1 (swine flu) vaccination market in these regions.


MARKET PLAYERS



The report covers key developments in the H1N1 (swine flu) vaccination market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from H1N1 (swine flu) vaccination market are anticipated to lucrative growth opportunities in the future with the rising demand for H1N1 (swine flu) vaccination in the global market. Below mentioned is the list of few companies engaged in the H1N1 (swine flu) vaccination market.

The report also includes the profiles of key H1N1 (swine flu) vaccination market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •  Novartis AG
  •  Baxter International Inc.
  •  CSL Limited
  •  AstraZeneca plc.
  •  Zydus Cadila
  •  MedImmune
  •  GlaxoSmithKline plc.
  •  sanofi-aventis U.S. LLC
  •  GREEN CROSS CORP.
  •  Serum Institute of India Pvt. Ltd.

The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

H1N1 (Swine Flu) Vaccination Report Scope

Report Attribute Details
Market size in 2024 US$ XX million
Market Size by 2031 US$ XX Million
Global CAGR (2025 - 2031) XX%
Historical Data 2021-2023
Forecast period 2025-2031
Segments Covered By Delivery Device
  • Syringes
  • Jet Injectors
  • Other Devices
By Route of Administration
  • Intradermal Vaccination
  • Intramuscular Vaccination
  • Subcutaneous Vaccination
By End User
  • Hospitals
  • Ambulatory Surgical Centers
  • Clinic & Vaccination Centers
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Novartis AG
  • Baxter International Inc.
  • CSL Limited
  • AstraZeneca plc.
  • Zydus Cadila
  • MedImmune
  • GlaxoSmithKline plc.
  • sanofi-aventis U.S. LLC
  • GREEN CROSS CORP.
    • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
    • PEST and SWOT Analysis
    • Market Size Value / Volume - Global, Regional, Country
    • Industry and Competitive Landscape
    • Excel Dataset
    h1n1-swine-flu-vaccination-market-report-deliverables-img1
    h1n1-swine-flu-vaccination-market-report-deliverables-img2
    Report Coverage

    Report Coverage

    Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

    Segment Covered

    Segment Covered

    This text is related
    to segments covered.

    Regional Scope

    Regional Scope

    North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

    Country Scope

    Country Scope

    This text is related
    to country scope.

    Trends and growth analysis reports related to Life Sciences : READ MORE..   

    H1N1 (Swine Flu) Vaccination Market
    Connect With Expert
    The List of Companies

    1. Novartis AG2. Baxter International Inc.3. CSL Limited4. AstraZeneca plc.5. Zydus Cadila6. MedImmune7. GlaxoSmithKline plc.8. sanofi-aventis U.S. LLC9. GREEN CROSS CORP.10. Serum Institute of India Pvt. Ltd.
    h1n1-swine-flu-vaccination-market-cagr